China Medicine Corporation, a leading distributor of prescription and over the counter (OTC) pharmaceutical products and traditional Chinese medicines (finished medicines made of Chinese herbs, has announced that the company's ADTZ (Aflatoxin-detoxifizyme) project has been selected by Guangdong Province as one of six patent commercialization projects.
These selected six projects will receive financial and other support from the provincial and local government in order to assist in the rapid commercialization of the technologies.
Mr Shenshan Yang, CEO of China Medicine, said, "Our ADTZ project has made tremendous progress and we believe that the financial and political support of the government will expedite commercialization of the product. We look forward to working closely with the government and a successful product launch."
China Medicine Corporation sells more than 1,100 products in over 28 provinces and is actively building a pipeline of proprietary traditional and Chinese herbal remedy products targeting oncology, high blood pressure and the removal of Aflatoxins from food and animal feed.